| Net earnings | 368.7M |
| Depreciation and amortization | 77.6M |
| Deferred income taxes | 31.9M |
| Stock-based compensation expense | 31.1M |
| Excess tax benefit related to exercises of stock options | |
| Net pension expense | 6.1M |
| Net realized (gain) loss from the sales of marketable securities | |
| Net amortization of premiums and accretion of discounts on available-for-sale securities | |
| Impairment losses on available-for-sale securities | |
| Impairment losses on assets held for sale | |
| (Loss) gain on sales of buildings | |
| Gain on sale of discontinued businesses, net of tax | |
| Other | 8.2M |
| (Increase) in accounts receivable | 121M |
| (Increase) decrease in other assets | -221.6M |
| (Decrease) increase in accounts payable | -36.3M |
| Increase (decrease) in accrued expenses and other liabilities | -80.1M |
| Operating activities of discontinued operations | |
| Net cash flows provided by operating activities | 329.8M |
| Purchases of corporate and client funds marketable securities | -1.17B |
| Proceeds from the sales and maturities of corporate and client funds marketable securities | 900.1M |
| Net increase in restricted cash and cash equivalents and other restricted assets held to satisfy client funds obligations | 9.16B |
| Capital expenditures | -48.7M |
| Additions to intangibles | -57.2M |
| Acquisitions of businesses, net of cash acquired | -20M |
| Reclassification from cash and cash equivalents to short-term marketable securities | |
| Proceeds from the sale of property, plant and equipment | |
| Other | |
| Investing activities of discontinued operations | |
| Proceeds from the sale of businesses included in discontinued operations | |
| Net cash flows used in investing activities | 8.76B |
| Net increase in client funds obligations | -8.93B |
| Proceeds from issuance of debt | |
| Payments of debt | -500K |
| Net purchases of reverse repurchase agreements | |
| Net (repayment) proceeds of commercial paper borrowing | |
| Repurchases of common stock | -328.6M |
| Proceeds from stock purchase plan and exercises of stock options | |
| Excess tax benefit related to exercises of stock options | |
| Dividends paid | -241.8M |
| Net cash flows provided by financing activities | -9.51B |
| Effect of exchange rate changes on cash and cash equivalents | 5.4M |
| Net change in cash and cash equivalents | -414.5M |
| Cash and cash equivalents of continuing operations, beginning of year | |
| Cash and cash equivalents of discontinued operations, beginning of year | |
| Cash and cash equivalents, end of year | |
| Less cash and cash equivalents of discontinued operations, end of year | |
| Cash and cash equivalents of continuing operations, end of year | |